REGULATION A+ OFFERING AGREEMENTRegulation A+ Offering Agreement • October 2nd, 2017 • Neurmedix, Inc. • Pharmaceutical preparations • California
The purpose of this engagement agreement (the “Agreement”) is to outline our agreement in principle pursuant to which WestPark Capital, Inc. ( “WestPark” or “Selling Agent”) will act as the lead managing selling agent and book runner in connection with a qualified primary offering by Neurmedix, Inc., a Delaware Corporation (the “Company”), currently anticipated to be between $20,000,000 and $50,000,000 of common stock, no par value per share, of the Company, and such other securities of the Company as may be appropriate on terms and conditions to be mutually agreed between the Company and the Selling Agent, as described herein.
